
	International Journal of Pharmacology
	Year: 2012 \| Volume: 8 \| Issue: 5 \| Page No.: 459-462 DOI: 10.3923/ijp.2012.459.462

Efficacies of Regulatory Policies to Control Massive Use of Diphenoxylate

Amir Farshchi, Mona Jaberidoost, Akbar Abdollahiasl and Mohammad Abdollahi

Abstract: Iran has been one of the highest users of diphenoxylate in the world in 2008. Iranian food and drug organisation (FDO) established some rules to control the usage of this drug included rationalizing the supply and doubling the price. Data were gathered from the distributors and wholesalers of this medicine in the country during 2006-2010. These data were cross-checked with importation data in the Ministry of Health and a trend analysis was tabulated. In 2009, the average consumption reached to less than 650 million tablets which show 42% decrease in comparison to the previous year. After the second intervention, there has been no significant change in the trend. The first intervention has controlled the use of diphenoxylate by reduction of market need and lessening diphenoxylate unauthorized use. Data do not support the efficiency of second intervention meaning that doubling the price does not work.

PDF Fulltext XML References Citation Report Citation

RELATED ARTICLES:

•	Cost and Utilization Study of Antidotes: An Iranian Experience

How to cite this article:

Amir Farshchi, Mona Jaberidoost, Akbar Abdollahiasl and Mohammad Abdollahi, 2012. Efficacies of Regulatory Policies to Control Massive Use of Diphenoxylate. International Journal of Pharmacology, 8: 459-462.

DOI: 10.3923/ijp.2012.459.462

URL: https://scialert.net/abstract/?doi=ijp.2012.459.462

COMMENT ON THIS PAPER

Navigation


		Online First
		Current Issue
		Previous Issues
		Editorial Board
		Submit a Manuscript
		Guide to Authors
		Subscribe to E-alerts

Indexed In


		ASCI-Database
		Asian Digital Library
		Chemical Abstract Services
		EMBASE
		Google Scholar
		ISI Web of Knowledge
		Science Citation Index (EXP)
		SCIMAGO
		Thomson ISI

Science Alert